Search clinical trials for: Tubulin Modulators

Total 21723 results

University of Vermont
National Cancer Institute (NCI)

Completed

Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia

Lymphoma | Leukemia

United States
Aichi Cancer Center

Completed

Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx

Head and Neck Cancer

Japan
SK Chemicals Co., Ltd.

Completed

Study to Evaluate SID 530 Compared to Taxotere

Non-Small Cell Lung Cancer

United States, India
National Taiwan University Hospital

Completed

Phase II Study of Docetaxel Plus CDDP for NSCLC Stage III

NSCLC

Taiwan
Seagen Inc.

Completed

FDG-PET to Investigate SGN-15 and Docetaxel in Patients With Advanced Non-Small Cell Lung Carcinoma

Non-Small Cell Lung Carcinoma

United States
University of Zurich

Completed

Patupilone (EPO 906) in Patients With Recurrent or Progressive Glioblastoma

Recurrent Glioblastoma Planned for Reoperation
Eurocor GmbH

Completed

The Valentines Trial

Instent Restenosis

Netherlands, Italy, Germany
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan

Tumors

Japan
Novartis Pharmaceuticals

Completed

Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies

Advanced Malignancies

United States
Sanofi

Completed

Efficacy and Safety of Subsequent Cisplatin and Docetaxel in Ovarian Cancer (Tax-Over)

Ovarian Neoplasms

Turkey
Sanofi

Completed

Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck Cancer

Cancer

United States, France, Canada, Russian Federation, Portugal, Argentina
GlaxoSmithKline

Completed

SB-715992 In Combination With Docetaxel In Patients With Solid Tumors

Solid Tumor Cancer

United Kingdom
National Cancer Institute (NCI)

Completed

A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With Leukemia

Leukemia | Acute Lymphocytic Leukemia

United States
Gustave Roussy, Cancer Campus, Grand Paris

Terminated

Trial of Docetaxel-Samarium in Patients With Hormone-Refractory Advanced Prostate Cancer

Prostate Cancer

France
MANTA 1 Study Italian Collaborative Group
Bristol-Myers Squibb

Unknown

Maintenance Chemotherapy in Metastatic Breast Cancer

Breast Cancer

Italy
Baker Norton Pharmaceuticals

Completed

Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals

HIV Infections | Sarcoma, Kaposi

United States
Kyowa Kirin, Inc.

Recruiting

A Study of KK2269 in Adult Participants With Solid Tumors

Gastric Adenocarcinoma | Non Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Esophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma

Japan
National Cancer Institute (NCI)

Recruiting

Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer

Squamous Cell Carcinoma of the Head and Neck | Drug Therapy | Oropharynx | Human Papillomavirus Viruses | Cancer Vaccine

United States
Xuekui Liu

Recruiting

Neoadjuvant Cadonilimab in Combination With Cisplatin and Nab-paclitaxel in Resectable Head and Neck Squamous Cell Carcinoma (NCCCNRHNSCC)

Head and Neck Squamous Cell Carcinoma | Locally Advanced Operable

China
AstraZeneca

Recruiting

Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC) (CAPItello280)

Prostate Cancer

United States, China, Israel, Korea, Republic of, Canada, Poland, Spain, Belgium, Hungary, Japan, United Kingdom, France, Brazil, Taiwan, Australia, Turkey, Chile, Czechia, India, Mexico, Netherlands, Greece
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Recruiting

A Study to Evaluate the Safety and Efficacy of Docetaxel for Injection (Albumin-bound)in Different Dose Regimens in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Assistance Publique Hopitaux De Marseille

Completed

Pharmacokinetics and Pharmacogenetics-based Adaptive Dosing of 5-fu (5-Fluorouracile) in Head & Neck Cancer Patient Undergoing Docetaxel, Cisplatin, 5-Fluorouracile (=TPF) Therapy (5-FU)

Patients With Head and Neck Cancer (ORL)

France
Spanish Breast Cancer Research Group
Novartis

Completed

Study of LDE225 (Sonidegib) in Combination With Docetaxel in Triple Negative (TN) Advanced Breast Cancer (ABC) Patients (EDALINE)

Advanced Breast Cancer

Spain
Children's Cancer Group, China

Completed

Vinorelbine for Recurrent ACLC

Anaplastic Large Cell Lymphoma | Vinorelbine

China
Cellxpert Biotechnology Corp.
Medigen Biotechnology Corporation

Completed

Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

Australia
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Study of SHR3680 in Combination With Docetaxel in the Treatment of mCRPC

Prostate Cancer Metastatic

China
OncoMed Pharmaceuticals, Inc.

Completed

A Study of Vantictumab (OMP-18R5) in Combination With Docetaxel in Patients With Previously Treated NSCLC

Solid Tumors

United States
Samsung Medical Center

Completed

Single-arm Study of Selumetinib in Combination With Docetaxel, in Advanced Gastric Adenocarcinoma Patients With Low/High MEK Signature, RAS Mutation or RAS Amplification as a Second-line Chemotherapy

Gastric Adenocarcinoma

Korea, Republic of
Peking Union Medical College

Unknown

Clinical Study on Drug Sensitivity Verification or Prediction of Therapy for Breast Cancer by Patient-Derived Organoid Model

Organoid

China
Istituto Scientifico Romagnolo per lo Studio e...

Completed

Study of Patient Preference for Oral or Intravenous Vinorelbine in the Treatment of Advanced NSCLC (VIVOS)

Non-small Cell Lung Cancer Metastatic

Italy
Montefiore Medical Center
National Cancer Institute (NCI)

Completed

Docetaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Yale University
National Cancer Institute (NCI)

Terminated

Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

United States
Leonard Appleman
Sanofi-Synthelabo

Completed

Study of Docetaxel and Oxaliplatin in Metastatic Transitional Cell Cancer (TCC) of the Urothelial Tract

Metastatic Transitional Cell Cancer of the Urothelial Tract

United States
Asan Medical Center
Novartis Pharmaceuticals

Completed

Dovitinib Plus Docetaxel in Gastric Cancer

Gastric Cancer

Korea, Republic of
Asan Medical Center
Boryung Pharmaceutical Co., Ltd

Unknown

Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer

Endometrial Cancer

Korea, Republic of
Merck Sharp & Dohme LLC

Terminated

Treatment With MK6592 and an Anti-cancer Drug in Patients With Advanced Solid Tumors (6592-001)

Advanced Solid Tumors
Hospices Civils de Lyon

Completed

STREAMER : STent Restenosis And MEdicaments Release (STREAMER)

Critical Ischemia

France
Pfizer

Withdrawn

A Study Of Docetaxel Or Docetaxel Plus PF-3512676 To Treat Patients With Advanced Breast Cancer.

Breast Neoplasms
National Cancer Institute (NCI)

Completed

Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma

Sarcoma | Ovarian Cancer

United States
Swiss Group for Clinical Cancer Research

Completed

Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer

Esophageal Cancer

Switzerland
Benaroya Research Institute
Sanofi; Cell Genesys

Terminated

Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate Cancer

Prostate Cancer

United States
University of Virginia
National Cancer Institute (NCI)

Completed

Surgery and Intrapleural Docetaxel in Treating Patients With Malignant Pleural Effusion

Metastatic Cancer

United States
Dana-Farber Cancer Institute
Bristol-Myers Squibb; Massachusetts General Hospital; Beth Israel Deaconess Medical... and other collaborators

Completed

A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer

Prostate Cancer

United States
Novartis Pharmaceuticals

Terminated

The Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies

Advanced Malignancies

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham...

Completed

Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma

Stomach Cancer | Gastric Cancer | Esophageal Cancer

United States
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Docetaxel and Carboplatin Versus Docetaxel as Second Line Treatment in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)

Non-Small Cell Lung Cancer

Greece
Point Therapeutics

Terminated

Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Carcinoma, Non-Small Cell Lung

United States
Memorial Sloan Kettering Cancer Center

Completed

Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Arcus Biosciences, Inc.

Recruiting

A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies (ARC-27)

Advanced Cancer

United States
Biotheus Inc.

Recruiting

A Study of PM8002 in Combination With Chemotherapy in Patients With SCLC

SCLC

China

3

Subscribe